• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎性肌病的评估与治疗

Evaluation and treatment of inflammatory myopathies.

作者信息

Amato A A, Barohn R J

机构信息

Department of Neurology, Brigham and Women's Hospital, Boston, MA 02115, USA.

出版信息

J Neurol Neurosurg Psychiatry. 2009 Oct;80(10):1060-8. doi: 10.1136/jnnp.2008.169375.

DOI:10.1136/jnnp.2008.169375
PMID:19762898
Abstract

The major types of idiopathic inflammatory myopathy include dermatomyositis (DM), polymyositis (PM), inclusion body myositis (IBM) and immune mediated necrotising myopathy (NM). These myositides appear clinically, histologically and pathogenically distinct. DM, PM and immune mediated NM are responsive to immunosuppressive therapy, in contrast with IBM which is generally refractory to therapy. Greater understanding of the pathogenic bases of these disorders should hopefully lead to better treatment. We need well designed, prospective, double blind, placebo controlled trials in order to determine the best therapeutic options for these different disorders.

摘要

特发性炎性肌病的主要类型包括皮肌炎(DM)、多发性肌炎(PM)、包涵体肌炎(IBM)和免疫介导坏死性肌病(NM)。这些肌炎在临床、组织学和发病机制上表现各异。与通常对治疗难治的IBM不同,DM、PM和免疫介导的NM对免疫抑制治疗有反应。对这些疾病发病机制基础的更深入了解有望带来更好的治疗效果。我们需要设计良好的前瞻性、双盲、安慰剂对照试验,以确定针对这些不同疾病的最佳治疗方案。

相似文献

1
Evaluation and treatment of inflammatory myopathies.炎性肌病的评估与治疗
J Neurol Neurosurg Psychiatry. 2009 Oct;80(10):1060-8. doi: 10.1136/jnnp.2008.169375.
2
Inflammatory myopathies: clinical, diagnostic and therapeutic aspects.炎症性肌病:临床、诊断及治疗方面
Muscle Nerve. 2003 Apr;27(4):407-25. doi: 10.1002/mus.10313.
3
Treatment of idiopathic inflammatory myopathies.特发性炎性肌病的治疗
Curr Opin Neurol. 2003 Oct;16(5):569-75. doi: 10.1097/01.wco.0000093099.34793.40.
4
Inflammatory myopathies.炎性肌病
Continuum (Minneap Minn). 2013 Dec;19(6 Muscle Disease):1615-33. doi: 10.1212/01.CON.0000440662.26427.bd.
5
Idiopathic inflammatory myopathies: a review.特发性炎性肌病:综述。
Intern Med J. 2021 Jun;51(6):845-852. doi: 10.1111/imj.15358.
6
[Idiopathic inflammatory myopathies. A review].[特发性炎性肌病。综述]
Rev Med Chil. 2019 Mar;147(3):342-355. doi: 10.4067/S0034-98872019000300342.
7
Idiopathic inflammatory myopathies.特发性炎性肌病
Handb Clin Neurol. 2014;119:495-512. doi: 10.1016/B978-0-7020-4086-3.00032-1.
8
[Therapeutic strategy in inflammatory myopathies (polymyositis, dermatomyositis, overlap myositis, and immune-mediated necrotizing myopathy)].炎症性肌病(多发性肌炎、皮肌炎、重叠性肌炎和免疫介导的坏死性肌病)的治疗策略
Rev Med Interne. 2014 Jul;35(7):466-71. doi: 10.1016/j.revmed.2013.09.008. Epub 2013 Oct 18.
9
Clinical Evaluation and Management of Inflammatory Myopathies.炎症性肌病的临床评估与管理
Semin Neurol. 2015 Aug;35(4):347-59. doi: 10.1055/s-0035-1558980. Epub 2015 Oct 6.
10
[Myositides: What is the current situation?].[肌炎:当前状况如何?]
Z Rheumatol. 2015 Aug;74(6):496-506. doi: 10.1007/s00393-014-1547-0.

引用本文的文献

1
Characteristics of Patients With Adult-Onset Dermatomyositis at 2 Tertiary Care Centres in Ontario, Canada.加拿大安大略省两家三级医疗中心成年起病皮肌炎患者的特征
J Cutan Med Surg. 2025 Mar-Apr;29(2):124-130. doi: 10.1177/12034754241301409. Epub 2024 Nov 26.
2
Intravoxel Incoherent Motion Diffusion-Weighted MRI, Fat Quantification, and Electromyography: Correlation in Polymyositis and Dermatomyositis.体素内不相干运动扩散加权 MRI、脂肪定量和肌电图:多发性肌炎和皮肌炎的相关性。
Tomography. 2024 Mar 1;10(3):368-377. doi: 10.3390/tomography10030029.
3
Dermatomyositis: Practical Guidance and Unmet Needs.
皮肌炎:实用指南与未满足的需求
Immunotargets Ther. 2024 Mar 6;13:151-172. doi: 10.2147/ITT.S381472. eCollection 2024.
4
PLIN4-related myopathy: clinical, histological and imaging data in a large cohort of patients.与PLIN4相关的肌病:大量患者队列的临床、组织学和影像学数据
J Neurol. 2023 Sep;270(9):4538-4543. doi: 10.1007/s00415-023-11729-8. Epub 2023 May 5.
5
Antinuclear Antibody (ANA) and Anti-Mi-2-Alpha Positive Dermatomyositis Hinting a Cancer Diagnosis.抗核抗体(ANA)和抗Mi-2-α阳性皮肌炎提示癌症诊断
Cureus. 2022 Feb 2;14(2):e21844. doi: 10.7759/cureus.21844. eCollection 2022 Feb.
6
Statin-naïve anti-3-hydroxy-3-methylglutaryl coenzyme A reductase antibody-positive necrotizing myopathy with heliotropic pseudoangioedema.初治他汀类药物的抗3-羟基-3-甲基戊二酰辅酶A还原酶抗体阳性伴向阳性假血管性水肿的坏死性肌病
JAAD Case Rep. 2022 Jan 25;21:198-200. doi: 10.1016/j.jdcr.2022.01.010. eCollection 2022 Mar.
7
A Case of Refractory Polymyositis Successfully Treated With Abatacept Monotherapy.1例用阿巴西普单药治疗成功的难治性多发性肌炎病例。
Arch Rheumatol. 2020 Feb 7;35(4):618-622. doi: 10.46497/ArchRheumatol.2020.7406. eCollection 2020 Dec.
8
Patient-reported dermatomyositis and polymyositis flare symptoms are associated with disability, productivity loss, and health care resource use.患者自述的皮肌炎和多发性肌炎发作症状与残疾、生产力丧失和医疗资源利用有关。
J Manag Care Spec Pharm. 2020 Nov;26(11):1424-1433. doi: 10.18553/jmcp.2020.26.11.1424.
9
Follicular lymphoma associated paraneoplastic myositis.滤泡性淋巴瘤相关副肿瘤性肌炎
Clin Case Rep. 2020 Jul 23;8(10):2003-2006. doi: 10.1002/ccr3.3046. eCollection 2020 Oct.
10
Investigating genetic drivers of dermatomyositis pathogenesis using meta-analysis.运用荟萃分析研究皮肌炎发病机制的遗传驱动因素。
Heliyon. 2020 Sep 24;6(9):e04866. doi: 10.1016/j.heliyon.2020.e04866. eCollection 2020 Sep.